STOCK TITAN

Colonnade Acquisition Corp. II Announces Pricing of $300 Million Initial Public Offering

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Rhea-AI Summary

Colonnade Acquisition Corp II announced its initial public offering (IPO) of 30 million units at $10.00 each, set to trade on the NYSE under symbol CLAA.U beginning March 10, 2021. Each unit includes one Class A ordinary share and one-fifth of a redeemable warrant, with whole warrants exercisable at $11.50. The IPO is expected to close on March 12, 2021, with Barclays Capital and Deutsche Bank as joint managers. The underwriters have a 45-day option to purchase an additional 4.5 million units. The SEC declared the registration effective on March 9, 2021.

Positive
  • Successful pricing of 30 million units at $10.00 each for the IPO.
  • Listing on the NYSE enhances visibility and credibility.
  • Potential to raise additional funds through the underwriters' over-allotment option.
Negative
  • None.

Colonnade Acquisition Corp. II (the “Company”) announced today the pricing of its initial public offering of 30,000,000 units at a price of $10.00 per unit. The units will be listed on the New York Stock Exchange (the “NYSE”) and trade under the ticker symbol “CLAA.U” beginning on March 10, 2021. Each unit consists of one Class A ordinary share and one-fifth of one redeemable warrant, with each whole warrant exercisable to purchase one Class A ordinary share at a price of $11.50 per share. After the securities comprising the units begin separate trading, the Class A ordinary shares and warrants are expected to be listed on the NYSE under the symbols “CLAA” and “CLAA WS,” respectively. The offering is expected to close on March 12, 2021.

Barclays Capital Inc. and Deutsche Bank Securities Inc. are acting as joint-book running managers of the offering. The Company has granted the underwriters a 45-day option to purchase up to an additional 4,500,000 units at the initial public offering price to cover over-allotments, if any.

A registration statement relating to these securities was declared effective by the U.S. Securities and Exchange Commission (the “SEC”) on March 9, 2021. This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

The offering is being made only by means of a prospectus. When available, copies of the prospectus relating to this offering may be obtained from Barclays Capital Inc., c/o Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, NY 11717, email: barclaysprospectus@broadridge.com, telephone: 1-888-603-5847, or Deutsche Bank Securities Inc., Attention: Prospectus Group, 60 Wall Street, New York, NY 10005-2836, by email at prospectus.CPDG@db.com, or by telephone at (800) 503-4611.

About Colonnade Acquisition Corp. II

Colonnade Acquisition Corp II is a blank check company incorporated for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. While the Company may pursue a business combination target in any business or industry, it intends to focus its search for a business combination on businesses with favorable growth prospects, that provide attractive risk-adjusted returns on invested capital, and offer compelling valuations relative to their peers.

Cautionary Note Concerning Forward-Looking Statements

This press release contains statements that constitute “forward-looking statements,” including with respect to the initial public offering and search for an initial business combination. No assurance can be given that the offering discussed above will be completed on the terms described, or at all, or that the proceeds of the offering will be used as indicated. Forward-looking statements are subject to numerous conditions, many of which are beyond the control of the Company, including those set forth in the Risk Factors section of the Company’s registration statement for the initial public offering filed with the SEC. Copies are available on the SEC’s website, www.sec.gov. The Company undertakes no obligation to update these statements for revisions or changes after the date of this release, except as required by law.

FAQ

What is the IPO price for Colonnade Acquisition Corp II?

The IPO price for Colonnade Acquisition Corp II is $10.00 per unit.

When will CLAA.U start trading on the NYSE?

CLAA.U is set to begin trading on the NYSE on March 10, 2021.

What does each unit of CLAA.U include?

Each unit consists of one Class A ordinary share and one-fifth of a redeemable warrant.

What is the exercise price for the warrants of CLAA.U?

The warrants can be exercised at a price of $11.50 per share.

What is the expected closing date of the IPO?

The IPO is expected to close on March 12, 2021.

CLAA.U

:CLAA.U

CLAA.U Rankings

CLAA.U Latest News

CLAA.U Stock Data